ICON9 Trial - check up the tenth and last - 14 September 2021
Jitteriness continued and with good cause it turns out. The scan I had on 9 September shows a couple (or three?) small nodules but also a 5cm mass in my lower abdomen which is causing the bowel symptoms. Dr M explains this as the olaparib keeping a lid on things relapsing in a widespread way but that some cells have become olaparib resistant. This marks the end of the ICON9 trial for me. It feels like a bit of a rushed consultation but it looks like I have two choices: 1. Go onto the next line of chemotherapy which would be carboplatin (again) plus gemcitabine - a three -weekly regimen but with an extra infusion of gemcitabine in the middle of the cycle, meaning something every 10 days; or 2. Enter a Phase 2A trial which would mean going back on olaparib plus a nanoparticle, being trialled by Ellipses Pharma, as yet unlicensed and known only as EP0057. As I understand it, the nanoparticle is a complex sugar molecule wrapped round a chemotherapy agent called camptothecin whic...